{"product_id":"enterogermina-2-miliardi-5ml-sospensione-orale-10-flaconcini-5ml","title":"Enterogermina 2 billion\/5ml oral suspension 10 vials 5ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment and prophylaxis of intestinal dysmicrobism and consequent endogenous vitamin deficiency. Therapy assists the restoration of the intestinal microbial flora, altered during antibiotic or chemotherapy treatments. Acute and chronic gastrointestinal disorders in infants, attributable to intoxications or intestinal dysmicrobisms and vitamin deficiency.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eSpecial warnings\u003c\/i\u003e Bacteremia\/sepsis Post-marketing cases of bacteremia, septicemia and sepsis have been reported in immunocompromised or seriously ill patients and in preterm infants. In the case of some critically ill patients, the outcome was fatal. ENTEROGERMINA should be avoided in these patient groups (see section 4.8). This medicine is for oral use only. Do not inject or administer by other routes. Incorrect use of the medicine has caused serious anaphylactic reactions such as anaphylactic shock. \u003ci\u003ePrecautions for use\u003c\/i\u003e During antibiotic therapy it is advisable to administer the preparation in the interval between one antibiotic administration and the next. The possible presence of visible corpuscles in the vials of ENTEROGERMINA is due to aggregates of spores of \u003ci\u003eBacillus clausii\u003c\/i\u003e; it is therefore not an indication of an altered product. Shake the vial before use.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following side effects have been observed during treatment with this medicinal product, classified according to the MedDRA classification by organ class and according to the following frequency classes: Very common (≥1\/10); common (≥1\/100,\u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000,\u003c1\/1,000); very rare \u003c1\/10,000); not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eClassification by systems and organs\u003c\/b\u003e | \u003cb\u003eMunicipality\u003c\/b\u003e | \u003cb\u003eUncommon\u003c\/b\u003e | \u003cb\u003eRare\u003c\/b\u003e | \u003cb\u003eVery rare\u003c\/b\u003e | \u003cb\u003eNot known\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInfections and infestations | \u003cb\u003eNot known\u003c\/b\u003e: Bacteremia, septicemia and sepsis (in immunocompromised or critically ill patients) (see section 4.4)\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders | \u003cb\u003eNot known\u003c\/b\u003e: hypersensitivity reactions, including skin rash, urticaria and angioedema\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions. \u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ehttps:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/u\u003e.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131234976071,"sku":"013046038","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-enterogermina-2-miliardi-5ml-sospensione-orale-10-flaconcini-5ml-farmacia-dottor-tili-1213792320.jpg?v=1767143388","url":"https:\/\/www.dottortili.com\/en-eu\/products\/enterogemine-2-billion-5ml-oral-suspension-10-vials-5ml","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}